Clinical Trial Update: Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the combination of cetuximab and paclitaxel in basal-like breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal-like Breast Cancer
• Breast Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Taxol (paclitaxel)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Breast Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN